113 related articles for article (PubMed ID: 37188622)
1. [Poly-G for tumor matched samples chronicles the evolution of human colorectal cancer].
Gao X; Yu T; Zhang Q; Zhang SY; Huang D; Zhao XY; Liu G
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):382-388. PubMed ID: 37188622
[No Abstract] [Full Text] [Related]
2. Hypermutable DNA chronicles the evolution of human colon cancer.
Naxerova K; Brachtel E; Salk JJ; Seese AM; Power K; Abbasi B; Snuderl M; Chiang S; Kasif S; Jain RK
Proc Natl Acad Sci U S A; 2014 May; 111(18):E1889-98. PubMed ID: 24753616
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA alteration in primary and metastatic colorectal cancer: Different frequency and association with selected clinicopathological and molecular markers.
Kleist B; Meurer T; Poetsch M
Tumour Biol; 2017 Mar; 39(3):1010428317692246. PubMed ID: 28345467
[TBL] [Abstract][Full Text] [Related]
5. Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers.
Cho SY; Chae J; Na D; Kang W; Lee A; Min S; Kang J; Choi B; Lee J; Sung CO; Chuang JH; Lee C; Lee WS; Park H; Kim JI
Clin Cancer Res; 2019 May; 25(9):2821-2834. PubMed ID: 30670495
[TBL] [Abstract][Full Text] [Related]
6. [Expression of stem cell markers CD44 and Lgr5 in colorectal cancer and its relationship with lymph node and liver metastasis].
Wang XF; Zhang XL; Xu LP; Shi GG; Zheng HY; Sun BC
Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2899-2904. PubMed ID: 30293346
[No Abstract] [Full Text] [Related]
7. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and molecular characterization of colorectal micropapillary carcinoma.
Verdú M; Román R; Calvo M; Rodón N; García B; González M; Vidal A; Puig X
Mod Pathol; 2011 May; 24(5):729-38. PubMed ID: 21336262
[TBL] [Abstract][Full Text] [Related]
9. Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis.
Wei Q; Ye Z; Zhong X; Li L; Wang C; Myers RE; Palazzo JP; Fortuna D; Yan A; Waldman SA; Chen X; Posey JA; Basu-Mallick A; Jiang BH; Hou L; Shu J; Sun Y; Xing J; Li B; Yang H
Ann Oncol; 2017 Sep; 28(9):2135-2141. PubMed ID: 28911083
[TBL] [Abstract][Full Text] [Related]
10. EGFR, HER2, and HER3 protein expression in paired primary tumor and lymph node metastasis of colorectal cancer.
Ye P; Li F; Wei Y; Zhang Y; Cui J; Dai R; Chen H; Xie J; Cai P
Sci Rep; 2022 Jul; 12(1):12894. PubMed ID: 35902718
[TBL] [Abstract][Full Text] [Related]
11. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing.
Cushman-Vokoun AM; Stover DG; Zhao Z; Koehler EA; Berlin JD; Vnencak-Jones CL
Clin Colorectal Cancer; 2013 Sep; 12(3):168-78. PubMed ID: 23773459
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of microsatellite instability in T1 colorectal cancer.
Kang J; Lee HW; Kim IK; Kim NK; Sohn SK; Lee KY
Yonsei Med J; 2015 Jan; 56(1):175-81. PubMed ID: 25510762
[TBL] [Abstract][Full Text] [Related]
14. Tumor Budding Detection by Immunohistochemical Staining is Not Superior to Hematoxylin and Eosin Staining for Predicting Lymph Node Metastasis in pT1 Colorectal Cancer.
Okamura T; Shimada Y; Nogami H; Kameyama H; Kobayashi T; Kosugi S; Wakai T; Ajioka Y
Dis Colon Rectum; 2016 May; 59(5):396-402. PubMed ID: 27050601
[TBL] [Abstract][Full Text] [Related]
15. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer.
Korphaisarn K; Pongpaibul A; Limwongse C; Roothumnong E; Klaisuban W; Nimmannit A; Jinawath A; Akewanlop C
World J Gastroenterol; 2015 Jan; 21(3):926-34. PubMed ID: 25624727
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
17. Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma.
Xue R; Li R; Guo H; Guo L; Su Z; Ni X; Qi L; Zhang T; Li Q; Zhang Z; Xie XS; Bai F; Zhang N
Gastroenterology; 2016 Apr; 150(4):998-1008. PubMed ID: 26752112
[TBL] [Abstract][Full Text] [Related]
18. Lymph Node Metastases in Colon Cancer Are Polyclonal.
Ulintz PJ; Greenson JK; Wu R; Fearon ER; Hardiman KM
Clin Cancer Res; 2018 May; 24(9):2214-2224. PubMed ID: 29203589
[No Abstract] [Full Text] [Related]
19. Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages.
Li W; Qiu T; Zhi W; Shi S; Zou S; Ling Y; Shan L; Ying J; Lu N
BMC Cancer; 2015 May; 15():340. PubMed ID: 25929517
[TBL] [Abstract][Full Text] [Related]
20. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]